Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
83.5M
-
Shares change
-
+2.14M
-
Total reported value, excl. options
-
$2.37B
-
Value change
-
+$83.2M
-
Put/Call ratio
-
1.77
-
Number of buys
-
102
-
Number of sells
-
-72
-
Price
-
$28.40
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q3 2018
216 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q3 2018.
Evolent Health, Inc. - Class A Common Stock (EVH) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83.5M shares
of 112M outstanding shares and own 74.78% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (7.64M shares), JPMORGAN CHASE & CO (7.19M shares), Vanguard Group Inc (5.71M shares), Bank of New York Mellon Corp (5.51M shares), BlackRock Inc. (4.57M shares), RIVERBRIDGE PARTNERS LLC (3.43M shares), DIMENSIONAL FUND ADVISORS LP (3.19M shares), EAGLE ASSET MANAGEMENT INC (2.54M shares), FMR LLC (2.4M shares), and BLAIR WILLIAM & CO/IL (2.14M shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.